Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial. [electronic resource]
Producer: 20150721Description: 875-84 p. digitalISSN:- 2213-8595
- Acromegaly -- drug therapy
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Female
- Human Growth Hormone -- blood
- Humans
- Insulin-Like Growth Factor I -- analysis
- Male
- Middle Aged
- Octreotide -- therapeutic use
- Peptides, Cyclic -- therapeutic use
- Somatostatin -- administration & dosage
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.